Global Motion Sickness Treatment Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 150
Status: Published
Report Code: ARI100995
Motion Sickness Treatment Market:
Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025. Continuous travel for business, fast growing tourism sector, rise in adoption of prescription motion sickness drugs, improvements in travel facilities and increase in awareness of the disease are likely to boost the growth of Global Motion Sickness Treatment Market.
Scope of Global Motion Sickness Treatment Market:
Motion sickness is a common disorder that occurs due to the vestibular disturbances and disagreement exists between vestibules, visual and Somatic Sensory systems of the body. It is a sensation of wooziness Pathogenesis of motion sickness is not understood completely. Motion sickness can be of various types based on their cause. Motion sickness is caused by disagreement signals in the inner ear, eyes, other body tissues and sensory receptors. It can be carsickness, seasickness, airsickness, or boat sickness depending on the motions exposed such as car travel, sea travel, air travel or boat travel even while being exposed to virtual reality (VR) such as VR games and simulations. The symptoms involved in motion sickness such as nausea, vomiting, dizziness, headache and irritability. Nausea is the most common symptoms among all these symptoms. Early symptoms of this disorder can include yawning, belching, hyper salivation, heartburn and frequent urination. Roughly 75% to 80% population suffers from motion sickness during travelling. The intensity of the motion sickness changes from person to person. Global motion sickness treatment market is segmented on the basis of route of administration, type, distribution channel and geography. On the basis of route of administration global motion sickness treatment market is segmented into oral, transdermal, parenteral and other. On the basis of type global motion sickness treatment market is segmented into anticholinergic, antihistamines sympathomimetic, traditional medicines and others. On the basis of distribution channel global motion sickness treatment market is segmented into retail pharmacies, online pharmacies, drug stores and others. The regions covered in global motion sickness treatment market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Motion Sickness Treatment Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Market Dynamics:
The occurrences of obesity-related disorders such as diabetes, cardiovascular diseases and others have considerably augmented in past few years are also boosting the growth of global motion sickness treatment market. Conferring to the United Nations World Tourism Organization (UNWTO), international tourist arrivals increased by 7% in 2017 as in the previous year and the inclination to expected to continue in the forecast period. Mediakix magazine published an article in 2017 concluded that there are 22.4 million Virtual Reality (VR) users in the U.S. Constant developments in motion sickness drug development and delivery systems is likely to expand acceptance of prescription drugs for motion sickness treatment. Nevertheless launching of generic transdermal scopolamine patches in the U.S. and accessibility of other such products in Asia Pacific are probable to impede the global motion sickness treatment market. Besides the global motion sickness treatment market is split with accessibility of large number of OTC products across the globe. Yet, rise in disposable income and increase in number of domestic and international travelers are expected to propel the global motion sickness treatment market in the future.
Regional Analysis:
In terms of revenue, North America was the leading market for Global Motion Sickness Treatment Market in 2017. Increased adoption of prescription motion sickness drugs in the U.S. is a chief factor for holding the large share of the region. Europe holds second position in the Global Motion Sickness Treatment Market. Rise in number of travelers is projected to expand the Global Motion Sickness Treatment Market in Europe. The region is estimated to account for 25% to 29% share of the global motion sickness treatment market during the forecast period. Asia Pacific has also been witnessed as the emerging global motion sickness treatment market in recent few years. Increase in disposable income and rise in number of domestic and international travelers are expected to boost the global motion sickness treatment market in Asia Pacific.
Key Players:
GlaxoSmithKline plc
Perrigo Company plc
Prestige Brands Inc.
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals Inc.
Myungmoon Pharm Co. Ltd.
Baxter International Inc.
Reliefband Technologies LLC.
CVS Health
Pfizer
Other
Motion Sickness Treatment Market Segmentation:
By Route of Administration
Oral
Transdermal
Parenteral
Other
By Type
Anticholinergic
Antihistamines Sympathomimetic
Traditional Medicines
Other
By Distribution Channel
Retail Pharmacies
Online Pharmacies
Drug stores
Other
By Region
North America - US, Mexico, Chile, Canada
Europe - UK, France, Germany, Italy
Asia Pacific - China, South Korea, Japan, India, Southeast Asia
Latin America - Brazil
Middle East and Africa - GCC, Africa, Rest of Middle East and Africa
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. Anticholinergic Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Motion Sickness Treatment Market
Chapter 5. Global Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
5.1. Global Motion Sickness Treatment Market Share, By Route of Administration, 2015 - 2028 (USD Million)
5.1.1. Oral
5.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.2. Transdermal
5.1.2.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.3. Parenteral
5.1.3.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.4. Other
5.1.4.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 6. Global Motion Sickness Treatment Market Overview, By Type, 2015 - 2028(USD Million)
6.1. Global Motion Sickness Treatment Market Share, By Type, 2015 - 2028 (USD Million)
6.1.1. Anticholinergic
6.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.2. Antihistamines Sympathomimetic
6.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.3. Traditional Medicines
6.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.4. Other
6.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 7. Global Motion Sickness Treatment Market Overview, By Distribution Channel, 2015 - 2028(USD Million)
7.1. Global Motion Sickness Treatment Market Share, By Distribution Channel, 2015 - 2028 (USD Million)
7.1.1. Retail Pharmacies
7.1.1.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.2. Online Pharmacies
7.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.3. Drug stores
7.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.4. Other
7.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 8. Global Motion Sickness Treatment Market Overview, By Geography, 2015 - 2028(USD Million)
8.1. Global Motion Sickness Treatment Market Share, By Geography, 2015 - 2028(USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2028 (%)
Chapter 9. North America Motion Sickness Treatment Market Overview, By Countries, 2015 - 2028(USD Million)
9.1. North America Motion Sickness Treatment Market Overview, 2015 - 2028 (USD Million)
9.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.2. North America Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.3. North America Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
9.1.4. North America Motion Sickness Treatment Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
9.1.5. North America Motion Sickness Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
9.1.5.1. U.S. Motion Sickness Treatment Market Overview, 2015 - 2028 (USD Million)
9.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.1.2. U.S. Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.5.1.3. U.S. Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Motion Sickness Treatment Market Overview, 2015 - 2028 (USD Million)
9.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.2.2. Canada Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.5.2.3. Canada Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Motion Sickness Treatment Market Overview, 2015 - 2028 (USD Million)
9.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.3.2. Mexico Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.5.3.3. Mexico Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Motion Sickness Treatment Market Overview, By Countries, 2015 - 2028(USD Million)
10.1. Europe Motion Sickness Treatment Market Overview, 2015 - 2028 (USD Million)
10.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.2. Europe Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
10.1.3. Europe Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
10.1.4. Europe Motion Sickness Treatment Market Overview, By Distribution Channel,2015 - 2028 (USD Million)
10.1.5. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2028 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.1.2. Germany Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.1.3. Germany Motion Sickness Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.2.2. France Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.2.3. France Motion Sickness Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.3.2. UK Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.3.3. UK Motion Sickness Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.4.2. Italy Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.4.3. Italy Motion Sickness Treatment Market Overview, By Type 2015 - 2028(USD Million)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.5.2. Spain Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.5.3. Spain Motion Sickness Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Size and projections, 2015 – 2028
10.1.5.6.2. Rest of Europe Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.6.3. Rest of Europe Motion Sickness Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Motion Sickness Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1. Asia Pacific Motion Sickness Treatment Market Overview, 2015 - 2028 (USD Million)
11.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.2. Asia Pacific Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.3. Asia Pacific Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
11.1.4. Asia Pacific Motion Sickness Treatment Market Overview, By Distribution Channel,2015 - 2028 (USD Million)
11.1.5. Asia Pacific Motion Sickness Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.1.2. India Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
11.1.5.1.3. India Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.2.2. China Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
11.1.5.2.3. China Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.3.2. Japan Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
11.1.5.3.3. Japan Motion Sickness Treatment Market Overview, By Type, 2015 - 2028(USD Million)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.4.2. South Korea Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
11.1.5.4.3. South Korea Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028(USD Million)
11.1.5.5.3. Rest of Asia Pacific Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Motion Sickness Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1. Middle East & Africa Motion Sickness Treatment Market Overview, 2015 - 2028 (USD Million)
12.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.2. Middle East & Africa Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.3. Middle East & Africa Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
12.1.4. Middle East & Africa Motion Sickness Treatment Market Overview, By Distribution Channel,2015 - 2028 (USD Million)
12.1.5. Middle East & Africa Motion Sickness Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.1.2. GCC Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.5.1.3. GCC Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.2.2. South Africa Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.5.2.3. South Africa Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
12.1.5.3.4. Other Segments
Chapter 13. South America Motion Sickness Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
13.1. South America Motion Sickness Treatment Market Overview, 2015 - 2028 (USD Million)
13.1.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.2. South America Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.3. South America Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
13.1.4. South America Motion Sickness Treatment Market Overview, By Distribution Channel,2015 - 2028 (USD Million)
13.1.5. South America Motion Sickness Treatment Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.6.2. Brazil Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.6.3. Brazil Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.7.2. Argentina Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.7.3. Argentina Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Size and projections, 2015 – 2028
13.1.8.2. Rest of South America Motion Sickness Treatment Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.8.3. Rest of South America Motion Sickness Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2021
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Size development
Chapter 15. Key Vendor Analysis
15.1. GlaxoSmithKline plc
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Route of Administration Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Perrigo Company plc
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Route of Administration Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Prestige Brands Inc.
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Route of Administration Benchmarking
15.3.4. Recent initiatives
15.4. WellSpring Pharmaceutical Corporation
15.5. Caleb Pharmaceuticals Inc.
15.6. Myungmoon Pharm Co. Ltd.
15.7. Baxter International Inc.
15.8. Others
Chapter 16. Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1. Motion Sickness Treatment Market Industrial Chain Analysis
16.2. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Client
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Route of Administration Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Route of Administration Progress in Related Size
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Motion Sickness Treatment Market, 2015-2028 (USD Million)
4. Biochemical Sensor requirement, by country, 2015-2028 (USD Million)
5. North America Motion Sickness Treatment Market, By Route of Administration, 2015-2028 (USD Million)
6. North America Motion Sickness Treatment Market, By Type, 2015-2028 (USD Million)
7. North America Motion Sickness Treatment Market, By Distribution Channel, 2015-2028 (USD Million)
8. Europe Motion Sickness Treatment Market, By Route of Administration, 2015-2028 (USD Million)
9. Europe Motion Sickness Treatment Market, By Type, 2015-2028 (USD Million)
10. Europe Motion Sickness Treatment Market, By Distribution Channel, 2015-2028 (USD Million)
11. Asia Pacific Motion Sickness Treatment Market, By Route of Administration, 2015-2028 (USD Million)
12. Asia Pacific Motion Sickness Treatment Market, By Type, 2015-2028 (USD Million)
13. Asia Pacific Motion Sickness Treatment Market, By Distribution Channel, 2015-2028 (USD Million)
14. Middle East & Africa Motion Sickness Treatment Market, By Route of Administration, 2015-2028 (USD Million)
15. Middle East & Africa Motion Sickness Treatment Market, By Type, 2015-2028 (USD Million)
16. Middle East & Africa Motion Sickness Treatment Market, By Distribution Channel, 2015-2028 (USD Million)
17. South America Motion Sickness Treatment Market, By Route of Administration, 2015-2028 (USD Million)
18. South America Motion Sickness Treatment Market, By Type, 2015-2028 (USD Million)
19. South America Motion Sickness Treatment Market, By Distribution Channel, 2015-2028 (USD Million)
20. Global Motion Sickness Treatment Market, Company Market Share, 2020 - 2028 (%)
21. GlaxoSmithKline plc: Route of Administration Benchmarking
22. GlaxoSmithKline plc: Financial Performance
23. Perrigo Company plc: Route of Administration Benchmarking
24. Perrigo Company plc: Financial Performance
25. Prestige Brands Inc.: Route of Administration Benchmarking
26. Prestige Brands Inc.: Financial Performance
27. Caleb Pharmaceuticals Inc.: Route of Administration Benchmarking
28. Caleb Pharmaceuticals Inc.: Financial Performance
29. Myungmoon Pharm Co. Ltd.: Route of Administration Benchmarking
30. Myungmoon Pharm Co. Ltd.: Financial Performance
31. Baxter International Inc.: Route of Administration Benchmarking
32. Baxter International Inc.: Financial Performance
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Motion Sickness Treatment Market share, By Route of Administration, 2020 & 2028 (%)
10. Global Motion Sickness Treatment Market share, by Oral, By Route of Administration, 2015 - 2028 (USD Million)
11. Global Motion Sickness Treatment Market share, by Transdermal, By Route of Administration, 2015 - 2028 (USD Million)
12. Global Motion Sickness Treatment Market share, by Parenteral, By Route of Administration, 2015 - 2028 (USD Million)
13. Global Motion Sickness Treatment Market share, by Other, By Route of Administration, 2015 - 2028 (USD Million)
14. Global Motion Sickness Treatment Market share, By Type, 2020 & 2028 (%)
15. Global Motion Sickness Treatment Market share, by Anticholinergic, By Type, 2015 - 2028 (USD Million)
16. Global Motion Sickness Treatment Market share, by Antihistamines Sympathomimetic, By Type, 2015 - 2028 (USD Million)
17. Global Motion Sickness Treatment Market share, by Traditional Medicines, By Type, 2015 - 2028 (USD Million)
18. Global Motion Sickness Treatment Market share, by Other, By Type, 2015 - 2028 (USD Million)
19. Global Motion Sickness Treatment Market share, By Distribution Channel, 2020 & 2028 (%)
20. Global Motion Sickness Treatment Market share, by Retail Pharmacies, By Distribution Channel, 2015 - 2028 (USD Million)
21. Global Motion Sickness Treatment Market share, by Online Pharmacies, By Distribution Channel, 2015 - 2028 (USD Million)
22. Global Motion Sickness Treatment Market share, by Drug Stores, By Distribution Channel, 2015 - 2028 (USD Million)
23. Global Motion Sickness Treatment Market share, by Other, By Distribution Channel, 2015 - 2028 (USD Million)
24. Global Motion Sickness Treatment Market share, by Region, 2020 & 2028 (%)
25. Global Motion Sickness Treatment Market share, by Region, 2015 - 2028(USD Million)
26. North America Motion Sickness Treatment Market, 2015 - 2028(USD Million)
27. North America Motion Sickness Treatment Market share, by Countries, 2020 & 2028 (%)
28. U.S. Motion Sickness Treatment Market, 2015 - 2028(USD Million)
29. Canada Motion Sickness Treatment Market, 2015 - 2028(USD Million)
30. Mexico Motion Sickness Treatment Market, 2015 - 2028(USD Million)
31. Europe Motion Sickness Treatment Market, 2015 - 2028(USD Million)
32. Europe Motion Sickness Treatment Market share, by Countries, 2020 & 2028 (%)
33. Spain Motion Sickness Treatment Market, 2015 - 2028(USD Million)
34. UK Motion Sickness Treatment Market, 2015 - 2028(USD Million)
35. Italy Motion Sickness Treatment Market, 2015 - 2028(USD Million)
36. Germany Motion Sickness Treatment Market, 2015 - 2028(USD Million)
37. France Motion Sickness Treatment Market, 2015 - 2028(USD Million)
38. Rest of Europe Motion Sickness Treatment Market, 2015 - 2028(USD Million)
39. Asia-Pacific Motion Sickness Treatment Market, 2015 - 2028(USD Million)
40. Asia-Pacific Motion Sickness Treatment Market share, by Countries, 2020 & 2028 (%)
41. China Motion Sickness Treatment Market, 2015 - 2028(USD Million)
42. India Motion Sickness Treatment Market, 2015 - 2028(USD Million)
43. Australia Motion Sickness Treatment Market, 2015 - 2028(USD Million)
44. Japan Motion Sickness Treatment Market, 2015 - 2028(USD Million)
45. Rest of Asia-Pacific Motion Sickness Treatment Market, 2015 - 2028(USD Million)
46. Middle East & Africa Motion Sickness Treatment Market, 2015 - 2028(USD Million)
47. Middle East & Africa Motion Sickness Treatment Market share, by Countries, 2020 & 2028 (%)
48. GCC Motion Sickness Treatment Market, 2015 - 2028(USD Million)
49. South Africa Motion Sickness Treatment Market, 2015 - 2028(USD Million)
50. Rest Of Middle East & Africa Motion Sickness Treatment Market, 2015 - 2028(USD Million)
51. South America Motion Sickness Treatment Market, 2015 - 2028(USD Million)
52. Brazil Motion Sickness Treatment Market, 2015 - 2028(USD Million)
53. Mexico Motion Sickness Treatment Market, 2015 - 2028(USD Million)
54. Argentina Motion Sickness Treatment Market, 2015 - 2028(USD Million)
55. Rest Of South America Motion Sickness Treatment Market, 2015 - 2028(USD Million)
The Leading Key Players in Global Motion Sickness Treatment Market 1
